Limitless movie poster (credit: Virgin Produced) Is it possible to rapidly increase (or decrease) the amount of information the brain can store?
Is it possible to rapidly increase (or decrease) the amount of information the brain can store?
A new international study led by the Research Institute of the McGill University Health Centre (RI-MUHC) suggests is may be. Their research has identified a molecule that improves brain function and memory recall is improved. Published in the latest issue of Cell Reports, the study has implications for neurodevelopmental and neurodegenerative diseases, such as autism spectral disorders and Alzheimer’s disease.
“Our findings show that the brain has a key protein called FXR1P (Fragile X Related Protein 1) that limits the production of molecules necessary for memory formation,” says RI-MUHC neuroscientist Keith Murai, the study’s senior author and Associate Professor in the Department of Neurology and Neurosurgery at McGill University. “When this brake-protein is suppressed, the brain is able to store more information.”
Murai and his colleagues used a mouse model to study how changes in brain cell connections produce new memories. When FXR1P was selectively removed from certain parts of the brain, new molecules were produced. They strengthened connections between brain cells, which correlated with improved memory and recall in the mice.Brain-disease link“The role of FXR1P was a surprising result,” says Murai. “Previous to our work, no-one had identified a role for this regulator in the brain. Our findings have provided fundamental knowledge about how the brain processes information. We’ve identified a new pathway that directly regulates how information is handled and this could have relevance for understanding and treating brain diseases.
“If we can identify compounds that control the braking potential of FXR1P, we may be able to alter the amount of brain activity or plasticity. For example, in autism, one may want to decrease certain brain activity and in Alzheimer’s disease, we may want to enhance the activity. By manipulating FXR1P, we may eventually be able to adjust memory formation and retrieval, thus improving the quality of life of people suffering from brain diseases.”
The study is described in an open-access paper in Cell Reports. Funding was provided by he Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada, and U.S. National Institutes of Health.